ACADIA Pharmaceuticals
ACAD
#3902
Rank
A$3.79 B
Marketcap
$22.86
Share price
-0.91%
Change (1 day)
-31.56%
Change (1 year)

ACADIA Pharmaceuticals (ACAD) - P/B ratio

P/B ratio as of October 2024 : 4.94

According to ACADIA Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 4.94.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

ACADIA Pharmaceuticals - P/B ratio (from 2004 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-3111.984.93%
2022-12-316.44-7.19%
2021-12-316.94-48.82%
2020-12-3113.642.66%
2019-12-319.5095.69%
2018-12-314.86-56.47%
2017-12-3111.265.55%
2016-12-316.74-62.96%
2015-12-3118.277.25%
2014-12-3110.3-17.89%
2013-12-3112.5211.52%
2012-12-314.0164.39%
2011-12-312.4453.46%
2010-12-311.59-61.92%
2009-12-314.18561.5%
2008-12-310.6314-82.45%
2007-12-313.60-8.17%
2006-12-313.92-7.02%
2005-12-314.2113.38%
2004-12-313.72
2003-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio differencediff. Country
0.5039-89.79%๐Ÿ‡บ๐Ÿ‡ธ USA
1.86-62.25%๐Ÿ‡บ๐Ÿ‡ธ USA
58.5 1,084.89%๐Ÿ‡บ๐Ÿ‡ธ USA
5.45 10.45%๐Ÿ‡บ๐Ÿ‡ธ USA
6.15 24.47%๐Ÿ‡บ๐Ÿ‡ธ USA